Sultosilic Acid

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0057775-26-5

Chemical Formula

C13-H12-O7-S2

Molecular Weight

344

Therapeutic Category

Antilipemic agent

Chemical Name

2,5-Dihydroxybenzenesulfonic acid 5-p-toluenesulfonate

Foreign Names

• Acido sultosilico (Latin)
• Sultosilinsäure (German)
• Acide sultosilique (French)
• Acidum sultosilicum (Spanish)

Generic Name

• A 585 (IS: Esteve)

Brand Name

• Mimedran
  Laboratorios Dr Esteve, Spain

International Drug Name Search

Glossary

IS	Inofficial Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Biotrex

Biotrex may be available in the countries listed below.

Ingredient matches for Biotrex

Levamisole

Levamisole is reported as an ingredient of Biotrex in the following countries:

• Bangladesh

International Drug Name Search

Decatylen

Decatylen may be available in the countries listed below.

Ingredient matches for Decatylen

Dequalinium Chloride

Dequalinium Chloride is reported as an ingredient of Decatylen in the following countries:

• Bahrain


• Estonia


• Georgia


• Switzerland

International Drug Name Search

Alkeran

Alkeran is a brand name of melphalan, approved by the FDA in the following formulation(s):

ALKERAN (melphalan - tablet; oral)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 2MG ^[RLD]

ALKERAN (melphalan hydrochloride - injectable; injection)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: November 18, 1992
  
  Strength(s): EQ 50MG BASE/VIAL ^[RLD][AP]

Has a generic version of Alkeran been approved?

Yes. The following products are equivalent to Alkeran:

melphalan hydrochloride injectable; injection

• 
  Manufacturer: BEDFORD LABS
  
  Approval date: October 28, 2010
  
  Strength(s): EQ 50MG BASE/VIAL ^[AP]


• 
  Manufacturer: BIONICHE PHARMA USA
  
  Approval date: October 27, 2009
  
  Strength(s): EQ 50MG BASE/VIAL ^[AP]


• 
  Manufacturer: SYNERX
  
  Approval date: June 9, 2009
  
  Strength(s): EQ 50MG BASE/VIAL ^[AP]

Note: No generic formulation of the following product is available.

• melphalan - tablet; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Alkeran. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Alkeran.

See also...

• Alkeran Consumer Information (Wolters Kluwer)
• Alkeran Tablets Consumer Information (Wolters Kluwer)
• Alkeran Consumer Information (Cerner Multum)
• Alkeran I.V. Consumer Information (Cerner Multum)
• Alkeran Advanced Consumer Information (Micromedex)
• Alkeran IV Advanced Consumer Information (Micromedex)
• Alkeran AHFS DI Monographs (ASHP)
• Melphalan Consumer Information (Wolters Kluwer)
• Melphalan Tablets Consumer Information (Wolters Kluwer)
• Melphalan Consumer Information (Cerner Multum)
• Melphalan Advanced Consumer Information (Micromedex)
• Melphalan Intravenous Advanced Consumer Information (Micromedex)
• Melphalan AHFS DI Monographs (ASHP)

Coloquinon

Coloquinon may be available in the countries listed below.

Ingredient matches for Coloquinon

Ubidecarenone

Ubidecarenone is reported as an ingredient of Coloquinon in the following countries:

• Japan

International Drug Name Search

Caluyon

Caluyon may be available in the countries listed below.

Ingredient matches for Caluyon

Tretoquinol

Tretoquinol hydrochloride (a derivative of Tretoquinol) is reported as an ingredient of Caluyon in the following countries:

• Japan

International Drug Name Search

Campath

In the US, Campath (alemtuzumab systemic) is a member of the drug class CD52 monoclonal antibodies and is used to treat Chronic Lymphocytic Leukemia and Rheumatoid Arthritis.

US matches:

• Campath

Ingredient matches for Campath

Alemtuzumab

Alemtuzumab is reported as an ingredient of Campath in the following countries:

• Argentina


• Peru


• Russian Federation


• United States

International Drug Name Search